Patient Reported Outcome Measures
29
8
9
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.4%
1 terminated out of 29 trials
90.9%
+4.4% vs benchmark
7%
2 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (29)
Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth
STAY-STRONG Study of Exercise Training During Chemotherapy
Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer
Cost Effectiveness of Various Implant Placement Protocols in the Esthetic Zone
Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population
At-home Breast Oncology Care Delivered With E-health Solutions
Patient-reported Outcomes and Esthetics With Single Dental Implants
Experiences and Health-related Quality of Life of Informal Caregivers of Dialysis Patients
The Effect of Digital Education for Osteoporosis Patients on Fracture Risk and Related Health Outcomes.
National Robotics-Assisted Radical Prostatectomy Database
Long Term Follow up of Toe-to-hand Transfers
The Effect of Preserving Inferior Pulmonary Ligamen on Symptom Burden in Thoracoscopic Pneumonectomy
Esophagus-sparing Radiotherapy for Metastatic Spinal Cord Compression.
The Possible Influence of Different Follow-up Modalities on Overall Survival in Ovarian Cancer
ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy
Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes
Translation and Validation of the Turkish Version of the ObsQoR-11 Questionnaire
Wearable and Patient-reported Outcome-based Continuous Assessment and Support Alerts in Palliative Care
ePRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors
Predicting Disease Progression and/or Recurrence in Cancer